To avoid competing with profitable products they already own, many pharmaceutical companies keep R&D in-house, retaining control of product development that outsourcing cannot guarantee, say researchers at Cornell and @umassamherst.bsky.social. #econsky www.aeaweb.org/research/org...
Limiting the cannibalization of existing patented products
